- Home
- ABLV vs CRIS Comparison
ABLV vs CRIS Comparison
Compare ABLV & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABLV
- CRIS
- Stock Information
- Founded
- ABLV 2015
- CRIS 2000
- Country
- ABLV China
- CRIS United States
- Employees
- ABLV N/A
- CRIS N/A
- Industry
- ABLV
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ABLV
- CRIS Health Care
- Exchange
- ABLV Nasdaq
- CRIS Nasdaq
- Market Cap
- ABLV 50.9M
- CRIS 21.3M
- IPO Year
- ABLV N/A
- CRIS 2000
- Fundamental
- Price
- ABLV $1.00
- CRIS $2.32
- Analyst Decision
- ABLV
- CRIS Strong Buy
- Analyst Count
- ABLV 0
- CRIS 2
- Target Price
- ABLV N/A
- CRIS $16.50
- AVG Volume (30 Days)
- ABLV 8.4K
- CRIS 71.8K
- Earning Date
- ABLV 04-23-2025
- CRIS 07-31-2025
- Dividend Yield
- ABLV N/A
- CRIS N/A
- EPS Growth
- ABLV N/A
- CRIS N/A
- EPS
- ABLV N/A
- CRIS N/A
- Revenue
- ABLV $128,932,647.00
- CRIS $11,202,000.00
- Revenue This Year
- ABLV N/A
- CRIS N/A
- Revenue Next Year
- ABLV N/A
- CRIS $10.67
- P/E Ratio
- ABLV N/A
- CRIS N/A
- Revenue Growth
- ABLV N/A
- CRIS 14.17
- 52 Week Low
- ABLV $0.55
- CRIS $1.02
- 52 Week High
- ABLV $1.90
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- ABLV 45.47
- CRIS 52.52
- Support Level
- ABLV $1.02
- CRIS $2.11
- Resistance Level
- ABLV $1.19
- CRIS $2.26
- Average True Range (ATR)
- ABLV 0.10
- CRIS 0.21
- MACD
- ABLV -0.01
- CRIS -0.04
- Stochastic Oscillator
- ABLV 32.31
- CRIS 21.36
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.